.

Make Better Decisions

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Mallinckrodt
Moodys
Dow
US Department of Justice
Daiichi Sankyo
Johnson and Johnson
UBS
Harvard Business School
Citi

Generated: December 14, 2017

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: ibrutinib

« Back to Dashboard

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Pharmacyclics IncIMBRUVICAibrutinibCAPSULE;ORAL205552NDAPharmacyclics LLC57962-140-12120 CAPSULE in 1 BOTTLE, PLASTIC (57962-140-12)
Pharmacyclics IncIMBRUVICAibrutinibCAPSULE;ORAL205552NDAPharmacyclics LLC57962-140-0990 CAPSULE in 1 BOTTLE, PLASTIC (57962-140-09)
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Citi
Federal Trade Commission
Covington
Moodys
Julphar
UBS
Medtronic
AstraZeneca
Argus Health
Harvard Business School

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot